Publicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (24)

2024

  1. Effectiveness of a Serious Video Game (MOON) for Attention Deficit Hyperactivity Disorder: Protocol for a Randomized Clinical Trial

    JMIR Research Protocols, Vol. 13, Núm. 1

2023

  1. Effects of elevated emotional symptoms on metabolic disease development: a 10-year follow-up study

    Frontiers in Psychiatry, Vol. 14

  2. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 121

2022

  1. Innovative approaches Pre-primary CLIL classrooms

    Addressing future challenges in early language learning and multilingual education (Dykinson), pp. 223-230

  2. Relación entre los estilos de vida saludables y el bienestar subjetivo: estudio observacional europeo

    Revista espanola de salud publica, Vol. 96

  3. Relación entre los estilos de vida saludables y el bienestar subjetivo: estudio observacional europeo

    Revista Espanola de Salud Publica, Vol. 96

  4. Relationship between immunometabolic status and cognitive performance among major depression disorder patients

    Psychoneuroendocrinology, Vol. 137

2021

  1. Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder

    Journal of Affective Disorders, Vol. 279, pp. 343-352

  2. Intracellular calcium and inflammatory markers, mediated by purinergic stimulation, are differentially regulated in monocytes of patients with major depressive disorder

    Neuroscience Letters, Vol. 765

  3. Metabolic dysregulation in older adults with depression and loneliness: The ATHLOS study

    Psychoneuroendocrinology, Vol. 123

  4. Screening for anxiety and depression in Primary Care: Utility of 2 brief scales adapted to the ICD-11-PC

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 4, pp. 196-201

2020

  1. Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked

    Current pharmaceutical design, Vol. 26, Núm. 20, pp. 2353-2362

2019

  1. Clinical and neurodevelopmental correlates of aggression in early psychosis

    Schizophrenia Research, Vol. 212, pp. 171-176

  2. Effective methods for knowledge transfer to strengthen mental health systems in low- And middle-income countries

    BJPsych Open, Vol. 5, Núm. 5

  3. Inflammatory and metabolic disturbances are associated with more severe trajectories of late-life depression

    Psychoneuroendocrinology, Vol. 110

  4. Mediterranean diet and wellbeing: evidence from a nationwide survey

    Psychology and Health, Vol. 34, Núm. 3, pp. 321-335

  5. WHO-mhGAP Training in Mexico: Increasing Knowledge and Readiness for the Identification and Management of Depression and Suicide Risk in Primary Care

    Archives of Medical Research, Vol. 50, Núm. 8, pp. 558-566

2018

  1. A multi-centre, randomised, double-blind, placebo-controlled clinical trial of methylphenidate in the initial treatment of acute mania (MEMAP study)

    European Neuropsychopharmacology, Vol. 28, Núm. 1, pp. 185-194

2016

  1. Effect of economic crises on suicide rates

    Understanding Suicide: From Diagnosis to Personalized Treatment (Springer International Publishing), pp. 191-198

  2. The influence of the COMT genotype in the underlying functional brain activity of context processing in schizophrenia and in relatives

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 71, pp. 176-182